AMRX - Amneal Pharmaceuticals Inc. (AMRX) CEO Chintu Patel on Q4 2020 Results - Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2020 Earnings Conference Call February 26, 2021 8:30 AM ET Company Participants Tasos Konidaris - Chief Financial Officer Chirag Patel - Co-Chief Executive Officer Chintu Patel - Co-Chief Executive Officer Joe Todisco - Chief Commercial Officers of Generics and Specialty Conference Call Participants David Amsellem - Piper Sandler Gary Nachman - BMO Capital Markets Elliot Wilbur - Raymond James Greg Gilbert - Truist Securities Balaji Prasad - Barclays Dana Flanders - Guggenheim Securities Presentation Operator Good morning and welcome to the Amneal Pharmaceuticals’ Fourth Quarter and Full Year 2020 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to, Tasos Konidaris, Executive Vice President and Chief Financial Officer. Please go ahead. Tasos Konidaris Good morning and thank you for joining us for Amneal's fourth quarter and
For further details see:
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q4 2020 Results - Earnings Call Transcript